In vitro and in vivo analysis of the effects of recombinant human granulocyte colony-stimulating factor in patients.

Twelve patients with small cell lung cancer were treated with recombinant human granulocyte colony-stimulating factor, rhG-CSF, given by continuous infusion at doses ranging from 1 to 40 micrograms kg-1 day-1. Patients received the rhG-CSF before the start of intensive chemotherapy and after alterna...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Bronchud, M. H., Potter, M. R., Morgenstern, G., Blasco, M. J., Scarffe, J. H., Thatcher, N., Crowther, D., Souza, L. M., Alton, N. K., Testa, N. G.
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group 1988
Teme:
Research Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2246501/
https://ncbi.nlm.nih.gov/pubmed/2458748
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items